Beclometasone/formoterol/glycopyrronium pMDI for severe asthma

Description

In this Product Explainer, Respiratory Physician Dr Andrew Scroop explains the role of beclometasone/ formoterol/ glycopyrronium pressurised metered dose inhalers (pMDIs) for maintenance treatment in adult patients with uncontrolled asthma despite treatment with an ICS and a LABA with a history of exacerbations (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Prof Dennis Lau

Prof Dennis Lau

Postural Orthostatic Tachycardia Syndrome – What You Need to Know

Prof Tony Attwood

Prof Tony Attwood

Autism Assessment in the GP Setting

Prof Brendon Yee, A/Prof Ralph Audehm

Prof Brendon Yee, A/Prof Ralph Audehm

Obstructive Sleep Apnoea – Practical Updates

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Dr Andrew Scroop

expert

Dr Andrew Scroop

Respiratory Physician; Founding Director of Respiratory Consultants, St Andrews Medical Centre

Date published: 24 January 2025